Detail
LncRNA Name | SNHG12 |
Synonyms | SNHG12, ASLNC04080, C1orf79, LINC00100, NCRNA00100, PNAS-123 |
Region | GRCh38_1:28578538-28582983 Sequence |
Ensembl | ENSG00000197989 |
RefSeq | NR_024127 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | osteosarcoma |
ICD-0-3 | M9180/3 |
Methods | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP |
Sample | osteosarcoma tissues, osteosarcoma cell lines (143B, U2OS, MG63 and HOS) |
Expression Pattern | up-regulated |
Function Description | SNHG12 was significantly upregulated in both osteosarcoma tissues and cell lines and osteosarcoma patients with high levels of SNHG12 tended to have a poor prognosis. Dual-luciferase reporter and RIP assays were conducted to confirm that SNHG12 functioned as a ceRNA, modulating the expression of Notch2 by sponging miR-195-5p in osteosarcoma. |
Pubmed ID | 29229388 |
Year | 2017 |
Title | LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p. |
External Links |
Links for SNHG12 | GenBank HGNC lncrnadb Noncode |
Links for osteosarcoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.